50
Participants
Start Date
April 28, 2023
Primary Completion Date
September 19, 2024
Study Completion Date
November 18, 2024
POLAT-001
Subjects will be randomized to receive three injections per under eyebag, either 1 mg/mL or 2 mg/mL and 120 microliter volume, at each of three treatment visits.
Placebo
Subjects will be randomized to receive three injections of 120 microliters total of Normal Saline per under eyebag at each of three treatment visits.
Skin Associates of South Florida, Coral Gables
Austin Institute for Clinical Research, Pflugerville
Medical Associates, Inc., Newport Beach
Lead Sponsor
Peregrine Ophthalmic
INDUSTRY